Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
gptkb:John_Sperzel
|
| gptkbp:focusesOn |
infectious disease detection
sepsis diagnostics |
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:Lexington,_Massachusetts,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
T2 Biosystems, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:numberOfEmployees |
100-200
|
| gptkbp:product |
gptkb:T2Bacteria_Panel
gptkb:T2Candida_Panel gptkb:T2Dx_Instrument gptkb:T2Resistance_Panel gptkb:T2SARS-CoV-2_Panel |
| gptkbp:publiclyTraded |
true
|
| gptkbp:specializesIn |
molecular diagnostics
diagnostic products magnetic resonance technology |
| gptkbp:stockSymbol |
gptkb:TTOO
|
| gptkbp:tradedOn |
gptkb:NASDAQ
|
| gptkbp:website |
https://www.t2biosystems.com/
|
| gptkbp:bfsParent |
gptkb:NASDAQ:TTOO
|
| gptkbp:bfsLayer |
7
|